Eli Lilly and drug makers show data on weight loss drugs
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Viking Therapeutics Inc.
The first drug for NASH liver disease is here, with more to come
3D illustration of a human liver organ. magic mine | iStock | fake images Do you think a friend or…
Viking Therapeutics emerges as a competitor
CR | Stock | fake images biotechnology company Viking therapeutics has become a strong potential entrant (or acquisition target) in…
Here's Eli Lilly's Competitive Advantage in GLP-1 Obesity Drugs and Abbott's Supporting Role
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
TJX quarter delivers and what Cramer expects to hear from Salesforce
Every weekday, the CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 a.m. ET. Here's a…
Viking Therapeutics' weight loss drug shows promising trial results
CR | Stock | fake images Actions of Viking therapeutics surged more than 80% in premarket trading on Tuesday after…
Boehringer Ingelheim, Terns and Viking could join the market
Still life of Wegovy, an injectable prescription weight loss medication that has helped people with obesity. It should be used…